Literature DB >> 3119339

The structure of a synthetic pepsin inhibitor complexed with endothiapepsin.

J Cooper1, S Foundling, A Hemmings, T Blundell, D M Jones, A Hallett, M Szelke.   

Abstract

The conformation of a synthetic polypeptide inhibitor, bound to the active site of the fungal aspartic proteinase endothiapepsin (EC 3.4.23.6), has been determined by X-ray diffraction at 0.20-nm resolution and refined to an agreement factor of 0.20. The inhibitor: Pro Thr Glu Phe-R-Phe Arg Glu (R = -CH2NH-) is based on a chromogenic substrate of pepsin (EC 3.4.23.1). It has, in place of the scissile bond, a reduced peptide group which is resistant to hydrolysis and mimics the tetrahedral transition state. The inhibitor binds in an extended conformation with the reduced bond close to the essential aspartate side-chains of the enzyme. The hydrogen bonds and hydrophobic interactions between the enzyme and the inhibitor do not induce large conformational changes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119339     DOI: 10.1111/j.1432-1033.1987.tb13600.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  9 in total

1.  Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes.

Authors:  N S Andreeva; L D Rumsh
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

Review 2.  Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

3.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1994-06       Impact factor: 3.686

4.  Identification of the aspartic proteinases from human erythrocyte membranes and gastric mucosa (slow-moving proteinase) as catalytically equivalent to cathepsin E.

Authors:  R A Jupp; A D Richards; J Kay; B M Dunn; J B Wyckoff; I M Samloff; K Yamamoto
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

5.  A structural comparison of 21 inhibitor complexes of the aspartic proteinase from Endothia parasitica.

Authors:  D Bailey; J B Cooper
Journal:  Protein Sci       Date:  1994-11       Impact factor: 6.725

6.  Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis.

Authors:  Peng Liu; Melissa R Marzahn; Arthur H Robbins; Hugo Gutiérrez-de-Terán; David Rodríguez; Scott H McClung; Stanley M Stevens; Charles A Yowell; John B Dame; Robert McKenna; Ben M Dunn
Journal:  Biochemistry       Date:  2009-05-19       Impact factor: 3.162

7.  Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents.

Authors:  C Abad-Zapatero; R Goldman; S W Muchmore; C Hutchins; K Stewart; J Navaza; C D Payne; T L Ray
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

8.  X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.

Authors:  D Bailey; J B Cooper; B Veerapandian; T L Blundell; B Atrash; D M Jones; M Szelke
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

9.  High-resolution X-ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme.

Authors:  A Sali; B Veerapandian; J B Cooper; S I Foundling; D J Hoover; T L Blundell
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.